| Combination of | |
|---|---|
| Sumatriptan | Triptan |
| Naproxen | Nonsteroidal anti-inflammatory drug (NSAID) |
| Clinical data | |
| Trade names | Treximet, Suvexx, others |
| AHFS/Drugs.com | Monograph |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Sumatriptan/naproxen, sold under the brand name Treximet among others, is a fixed-dose combination medication used to treat migraines.[2] It is taken by mouth.[2] It contains sumatriptan, as the succinate, a serotonin 5-hydroxytryptamine (5-HT) 1b/1d receptor agonist (triptan); and naproxen as the sodium salt, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs).[2]